Traws Pharma (TRAW) Depreciation & Amortization (CF) (2016 - 2025)
Traws Pharma (TRAW) has disclosed Depreciation & Amortization (CF) for 14 consecutive years, with $44000.0 as the latest value for Q4 2025.
- For Q4 2025, Depreciation & Amortization (CF) rose 2100.0% year-over-year to $44000.0; the TTM value through Dec 2025 reached $61000.0, up 408.33%, while the annual FY2025 figure was $61000.0, 408.33% up from the prior year.
- Depreciation & Amortization (CF) hit $44000.0 in Q4 2025 for Traws Pharma, up from $15000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $44000.0 in Q4 2025 and bottomed at $1000.0 in Q1 2025.
- Average Depreciation & Amortization (CF) over 5 years is $5850.0, with a median of $4000.0 recorded in 2021.
- On a YoY basis, Depreciation & Amortization (CF) climbed as much as 2100.0% in 2025 and fell as far as 75.0% in 2025.
- Traws Pharma's Depreciation & Amortization (CF) stood at $4000.0 in 2021, then changed by 0.0% to $4000.0 in 2022, then changed by 0.0% to $4000.0 in 2023, then crashed by 50.0% to $2000.0 in 2024, then surged by 2100.0% to $44000.0 in 2025.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $44000.0, $15000.0, and $1000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.